Emerging International Pharmaceutical Enterprise Signs Agreements with eResearchTechnology for Cardiac Safety Monitoring and Inf
09 December 2003 - 1:01AM
PR Newswire (US)
Emerging International Pharmaceutical Enterprise Signs Agreements
with eResearchTechnology for Cardiac Safety Monitoring and
Information Distribution Services Awards Total Approximately $2.2
million and Include Digital Collection, Interpretation, and
Distribution of Cardiac Safety Data PHILADELPHIA, Dec. 8
/PRNewswire/ -- eResearchTechnology, Inc. (eRT), , a leading
provider of centralized electrocardiographic (ECG) collection and
interpretation services, announced today that it has received
agreements for approximately $2.2 million in cardiac safety
monitoring and services from an emerging international
pharmaceutical organization for one of its drug candidates in late
phase development. The agreements cover a Phase III study that will
be conducted at 186 research sites on three continents and
retrospective analysis of ECGs that were collected during a
previous study for the same compound. eRT will provide
comprehensive site support and 186 units of 12-lead ECG recording
equipment, which is designed to facilitate the collection of
cardiac safety data that are subsequently provided to eRT for
analysis. eRT will manage collection, measurement, interpretation,
review, and distribution of cardiac safety data through its EXPeRT
workflow enabled data handling technology, the first solution in
production that was designed explicitly to meet emerging
international regulatory guidance and technical standards. "These
exciting awards are indicative of two related key trends in today's
market for ECG core laboratory services," said Scott Grisanti,
senior vice president of business development and chief marketing
officer at eRT. "The Phase III study, which includes 186 sites on
three continents, exemplifies the type of massively distributed
later phase studies being driven by regulatory guidance. These
trials require a cardiac safety partner with the infrastructure to
provide logistics and site support services across a far-flung
investigator network. The retrospective award represents a
continuing trend among sponsors to centralize analysis of cardiac
safety data collected during previous studies to strengthen
compliance with the emerging guidance." Based in Philadelphia, PA,
eResearchTechnology, Inc. (http://www.ert.com/) is a provider of
technology and services to the pharmaceutical, biotechnology and
medical device industries on a global basis. The company is a
market leader in providing centralized core-diagnostic
electrocardiographic (ECG) technology and services to evaluate
cardiac safety in clinical development. The company is also a
leader in providing technology and services to streamline the
clinical trials process by enabling its customers to automate the
collection, analysis, and distribution of clinical data in all
phases of clinical development. Statements included in this release
may constitute forward-looking statements within the meaning of the
Private Securities Litigation Reform Act of 1995. Such statements
involve a number of risks and uncertainties such as competitive
factors, technological development, market demand, and the
company's ability to obtain new contracts and accurately estimate
net revenues due to variability in size, scope and duration of
projects, and internal issues in the sponsoring client. As a
result, actual results may differ materially from any financial
outlooks stated herein. Further information on potential factors
that could affect the company's financial results can be found in
the company's Reports on Forms 10-K and 10-Q filed with the
Securities and Exchange Commission. DATASOURCE:
eResearchTechnology, Inc. CONTACT: Joan Sterlacci of
eResearchTechnology, Inc., +1-908-203-6473; Matt Hayden of Hayden
Communications, +1-760-487-1137, for eResearchTechnology, Inc. Web
site: http://www.ert.com/
Copyright
East Resources Acquisition (NASDAQ:ERES)
Historical Stock Chart
From Jun 2024 to Jul 2024
East Resources Acquisition (NASDAQ:ERES)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about East Resources Acquisition Company (NASDAQ): 0 recent articles
More Eresearch Tech (MM) News Articles